ANPEP and neoplasm: The recently described “Sequentially Tumor-selected Antibody and antigen Retrieval (STAR)” method led to isolation of nanobodies that preferentially bound acute myeloid leukemia (AML) cells, and identified CD13 as an AML-specific target (127).